Pain Reliever Composition
OwnerHoward Roseninventor
Life of this patent
Estimating the term…
Abstract
A pain reliever comprised of dextrose, aloe vera concentrate, and some or all of the following ingredients: propylene glycol, caprylic/capric tryglicerides, sodium chloride (or acetic acid), a homeopathic anti-inflamatory extract, Dimethyl Sulfone (or Methylsulfonylmethane (MSM)), cetyl myristoleate, and, optionally, a pitcher plant extract. The resulting compositions are a water-based solution and two gel composition applied to the epidermis of mammals for relieving pain.
Claims14
A water-based pain reliever composition applied to the epidermis of mammals comprised of
- anhydrous dextrose or hypertonic saline;
- aloe vera concentrate;
- propylene glycol;
- sterile water;
- and
- any one of the following:
- sodium chloride, acetic acid or hypertonic saline;
- all in amounts ranging from 0.01% to 75% of the composition.
A gel-based pain reliever composition applied to the epidermis of mammals comprised of anhydrous dextrose or hypertonic saline, aloe vera concentrate, propylene glycol, caprylic/capric triglycerides, ultrasound gel, and simple-gel (Hawkins), in amounts ranging from 0.01% to 75% of the composition.
The pain reliever composition of claim 54, wherein, out of a 100 gram composition,
- 2-50 grams is anhydrous dextrose;
- 5-10 grams is aloe vera concentrate;
- 1-20 ml is propylene glycol;
- 0.5-5 ml is caprylic/capric triglycerides;
- 10-100 grams is ultrasound gel, and
- 0.25-5 ml is simple-gel (Hawkins) gel.
A gel-based pain reliever composition applied to the epidermis of mammals comprised of anhydrous dextrose, aloe vera concentrate, ethoxy diglycol reagent, caprylic/capric triglycerides, lipoderm base, and cetyl myristoleat, in amounts ranging from 0.01% to 75% of the composition;
- the lipoderm base being substitutable by any of the following:
- lecthicin or other fat soluble granules in the range of 0.001 to 75% (w/w) of the composition;
- PLO(Pluronic Lecithin Organogel) in the range of 0.001 to 75% of the composition in gel form;
- Urea in the range of 1-50% of the composition;
- Oleic acid in the range of 0.001 to 70% of the composition;
- Liposomes in the range of 0.01% to 75% of the composition;
- Niosomes in the range of 0.01% to 75% of the composition;
- or
- Nanotechnology in the range of 0.01 to 75% chosen from a group consisting of
- nanocrystals, liposomes, nanoparticle-protein conjugates, magnetic
- nanoparticles, nanogels and biodegradable nanoparticles.
Dependencies are inferred from the claim text.